Navigate today’s most pressing health industry challenges with a leading global expert by your side.
Meet growing needs for innovative insurance solutions while increasing operational health and improving compliance.
Deliver on the promises of the past and create smart solutions for the future.
Manage complex risks using data-driven insights, advanced approaches, and deep industry experience.
This is a place where your ideas and insights make an impact. Where an independent, entrepreneurial spirit is an advantage. And where diversity of thought and experience makes us who we are.
Data-driven insight. Deep expertise. Transformative innovation. Since 1947, Milliman has delivered intelligent solutions to improve health and financial security.
Scott Chow is a consulting actuary with Milliman’s life insurance consulting practice in Hong Kong. He has worked on a number of important projects in the Asia Pacific region, especially Hong Kong.
Scott currently leads two working groups focusing on the developing Hong Kong Risk-Based Capital framework and InsurTech to enhance Milliman’s service offerings in the region.
Scott is a seasoned consultant with broad experience in different actuarial topics, including but not limited to merger and acquisitions, product development and pricing, product and distribution strategy, supporting appointed / independent actuary and risk-based capital-related projects. He has advised companies in different parts of Asia. Some of the past key projects he worked on include:
Apart from his consulting work, Scott is also a frequent speaker in various actuarial conferences on InsurTech or risk-based capital-related topics. He also serves on related committees for the ASHK and the SOA.
Before joining Milliman, Scott worked in the Solvency II and economic capital team at the regional office of Prudential Asia. He was responsible for maintaining the Internal Capital Model of the company and helped on solvency reporting under Solvency II framework, covering business in Hong Kong, Singapore, Korea, Taiwan, and China.